SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
-0.75%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$211K
AUM Growth
-$223M
(-100%)
Cap. Flow
-$26.3M
Cap. Flow
% of AUM
-12,436.59%
Top 10 Holdings %
Top 10 Hldgs %
55.44%
Holding
84
New
12
Increased
41
Reduced
10
Closed
15
Top Buys
| 1 |
Athira Pharma
ATHA
|
$27K |
| 2 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$8.06K |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.97K |
| 4 |
Veracyte
VCYT
|
$5.63K |
| 5 |
Apellis Pharmaceuticals
APLS
|
$5.35K |
Top Sells
| 1 |
RACB
Research Alliance Corp. II Class A Common Stock
RACB
|
$5.42M |
| 2 |
Halozyme
HALO
|
$2.86M |
| 3 |
Cytokinetics
CYTK
|
$2.65M |
| 4 |
Aurinia Pharmaceuticals
AUPH
|
$2.29M |
| 5 |
BridgeBio Pharma
BBIO
|
$1.67M |
Sector Composition
| 1 | Healthcare | 98.52% |
| 2 | Financials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
|
AKLI
77
DELISTED
Akili, Inc. Common Stock
AKLI
| – | – |
-123,862
| Closed | -$1.23M |
|
|
DCPH
78
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-160,526
| Closed | -$1.57M |
|
|
ISEE
79
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
0
| – | – |
|
|
DNAD
80
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
| – | – |
-123,862
| Closed | -$1.22M |
|
|
DNAB
81
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
| – | – |
-123,862
| Closed | -$1.23M |
|
|
APTX
82
DELISTED
Aptinyx Inc. Common Stock
APTX
| – | – |
0
| – | – |
|
|
RACB
83
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| – | – |
-556,890
| Closed | -$5.42M |
|
|
INBX
84
DELISTED
Inhibrx, Inc. Common Stock
INBX
| – | – |
-24,666
| Closed | -$1.08M |
|